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ABSTRACT
Background. Near infrared spectroscopy 
(NIRS) is a new, non-invasive monitoring 
method in neonates, which has now be-
come part of routine monitoring in many 
neonatal intensive care units (NICU). New, 
additional, non-invasive technical moni-
toring might have an influence on neonatal 
wellbeing.
Objectives. The aim of the present study 
was to evaluate the wellbeing of neonates 
during peripheral and cerebral NIRS mon-
itoring and venous occlusions.
Methods. In the present study, secondary 
outcome parameters of prospective ob-
servational studies with NIRS in term and 
preterm neonates were analysed. Heart rate 
(HR), arterial oxygen saturation (SpO2), 
respiratory rate (RR), mean arterial blood 
pressure (MABP), pain score and skin 
condition at four defined time points dur-
ing NIRS measurements of regional tissue 
oxygenation were recorded and analysed.
Results. Thirty-six term and preterm neo-
nates were included (gestational age (GA) 
36±1 week, 2779±930g birth weight). 
SpO2 and peripheral tissue oxygenation 
index (pTOI) increased and HR dropped 
while RR, mean MABP and pain scores re-
mained unchanged during NIRS measure-
ments. In eight infants, a mildly irritated 
area of skin was noted where the NIRS sen-
sors had been attached.
Conclusion. Cerebral and peripheral NIRS 
monitoring and venous occlusions were 
painless and well tolerated by term and 
preterm neonates.
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INTRODUCTION
In 1977 Jöbsis (1) described a new means 
of monitoring regional tissue oxygen satu-
ration, with near infrared spectroscopy 
(NIRS), which has now become part of 
routine monitoring in many neonatal in-
tensive care units. By applying sensors to 
the skin, NIRS is able to estimate regional 
oxygen saturation in various regions of 
interest (brain, muscle, kidney, liver etc.) 
noninvasively and continuously. (2) For 
cerebral NIRS measurements, sensors are 
often attached to the forehead, for periph-
eral measurements they are attached to the 
skin at the area of interest – e.g. abdominal 
skin closest to kidney or liver. For periph-
eral muscle measurements the sensors are 
attached on the skin of the lower or upper 
limb and measurements can be combined 
with the venous occlusion techniques. (3-
5)
NIRS is non-invasive which makes it ideal 
for routine purposes in addition to arterial 
oxygen saturation (SpO2), electrocardio-
gram (HR), oscillometric blood pressure 
monitoring or temperature measurements. 
Depending on the type of NIRS meas-
urement it can be attached to the skin by 
means of either a probe holder and an ad-
hesive strip or an elastic bandage. During 
routine care the sensors can be attached 
securely to permit uncompromised posi-
tioning on the infants.
Every intervention in term and preterm 
neonates might cause discomfort and 
might not be well tolerated. Therefore, af-
ter introduction of new monitoring in neo-
nates, it is necessary to evaluate tolerance 
and influence on well-being. Response to 
discomfort or pain can be evaluated in 
term and preterm neonates with scoring 
systems that include different items, such 
as facial expression, changes in motor be-
haviour and alterations in vital parameters. 
(6,7)
The aim of this study was to evaluate the 
impact of peripheral and cerebral NIRS 
monitoring and peripheral occlusions on 
vital parameters, pain score and skin in-
tegrity and to make a judgement on toler-
ance of these measurements. (8) For this 
purpose we recorded vital parameters, 
pain scores, skin condition and duration of 
manipulation. We hypothesised that NIRS 
measurements are well tolerated with no 
influence on vital parameters, pain score 
and skin integrity.
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METHODS
In a prospective observational study with 
NIRS (EK.NR: 21-149 ex 09/10), we in-
cluded term and preterm neonates who 
were admitted to our neonatal intensive 
care unit. Written consent of parents was 
obtained prior to inclusion in the study.
Standard monitoring during NIRS meas-
urements consisted of HR with electro-
cardiogram, SpO2 with pulse-oximetry at-
tached to the left foot, respiratory rate (RR), 
and a blood pressure measurement with the 
cuff applied to the left thigh (Philips Inteli 
View MP50 Netherland). NIRS measure-
ments were performed using the NIRO 300 
(Hamamatsu Photonics, Japan). The sensor 
for cerebral measurements (cTOI- cerebral 
tissue oxygenation index) was attached to 
the forehead using elastic bandaging and 
probe holder. The sensor for peripheral 
muscle measurement (pTOI- peripheral 
tissue oxygenation index) was attached to 
the left calf using a probe holder, adhesive 
strip and adhesive bandage. The tempera-
ture probe was fixed next to pTOI. In all 
infants both peripheral and cerebral NIRS 
measurements were done simultaneously. 
NIRS measurements of pTOI followed a 
standardised protocol using intermittent 
inflations of a blood pressure cuff causing 
venous occlusion in the left thigh still per-
mitting arterial perfusion. (3-5) After the 
attachment of sensors and after the infant 
was settled three consecutive venous occlu-
sions were performed with rest periods of 
one minute between occlusions. The blood 
pressure cuff was inflated for 20 seconds to 
a pressure of between 20 and 40 mmHg for 
venous occlusions.
We defined four time points for measure-
ments of vital parameters and pain score: 
before manipulation of the infant, after 
attachment of sensors, before the first ve-
nous occlusion and after measurement and 
removal of sensors. At each time point we 
recorded HR, SpO2, RR and mean arterial 
blood pressure (MABP) as routine param-
eters and in addition cTOI and pTOI with 
NIRS. The sensors were removed using 
Dermasol®. We checked the skin once be-
fore and once after NIRS measurements 
and classified the local skin as not irritated, 
mildly irritated, moderately irritated or as 
loss of integrity. Central and peripheral 
temperature was measured before manipu-
lation and after the fourth time point.
In infants without respiratory support 
scoring was done using the KUSS scoring 
system which is an infant discomfort and 
pain score. (9) We used the KUSS score to 
quantify discomfort and pain, because it is 
validated for infants from birth to the age 
of 4 years, and because it as a score, which 
is validated for the German language. It 
looks at infant behaviour and movement 
by evaluating 5 items – crying, facial ex-
pression, posture of trunk, posture of legs, 
and hyperactivity. Behaviour is scored 
between zero and two points, thus show-
ing a maximum scoring of ten points, and 
a minimum of zero points. (9) A value of 
four points is considered as cut off value 
for start of pharmacological pain therapy. 
The scoring was done before manipulation 
and after measurement in 15 sec.
Vital parameters and KUSS score at time 
points two, three and four were compared 
to readings at time point one by means of 
ANOVA for repeated measurements or 
Friedman’s Test. Post hoc tests for analys-
ing changes from time point 1 to all other 
time points were done using paired t-Test 
or Wilcoxon signed-rank test. Regional 
cerebral and peripheral oxygenation at 
time points three and four were compared 
to readings at time point two by means of 
ANOVA for repeated measurements. Post 
hoc tests to analyse changes from time 
point 2 to all other time points were done 
using paired t-Test.
RESULTS
From August 2010 until July 2011 we 
were able to include 36 term and pre-
term infants in our study. Demographic 
data are presented in table 1. Duration of 
NIRS measurements was 61± 17 minutes 
(mean± SD). None of the infants expe-
rienced respiratory or circulatory prob-
lems or were treated with sedatives during 
measurements. HR at time point 2, 3 and 
4 was significantly lower compared to HR 
at time point 1. SpO2 at time point 2 and 3 
was significantly higher than at time point 
1 (table 2). No change of RR, MABP and of 
KUSS score was observed at different time 
points. cTOI levels were stable throughout 
measurements, whereas pTOI was signifi-
cantly higher at time point 3 compared to 
time point 2 (table 3). There were no skin 
irritations on the forehead after measure-
ments, whereas eight infants showed mild-
ly irritated skin after removal of sensors 
from the lower limb. 
Table 1. Demographic data for 36 term and preterm neonates.
Gestational age (week) 36.1±1
Postnatal age (d) 2±1
Birth weight (g) 2779±930
Actual weight (g) 2747±912
Temperature, peripheral (°C) 35±0.5
Temperature, rectal (°C) 37±0.3
Average duration (min.) 61±17
mean score ± standard deviation
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Table 2. Vital parameters and KUSS score during the near infrared spectroscopy (NIRS) measurements in 36 term and preterm neonates.
























































mean±standard deviation, median(range); * p-value < 0.05 for comparison to time point “Before manipulation”, p-values, T-values for 
paired t-Test and Z-values for Wilcoxon signed-rank test are given.
Table 3. Near infrared spectroscopy (NIRS) parameters for 36 term and preterm neonates.
After attachment Before occlusion After measurement


















mean±standard deviation; * p-value < 0.05 for comparison to time point “After attachment”, p-values and T-values for paired t-Test are 
given.
DISCUSSION
Based on the evaluation of vital param-
eters, pain scores and clinical observation 
in the present study, peripheral or cerebral 
NIRS measurements do not pose a signifi-
cant burden on the wellbeing of term and 
preterm neonates.
According to Gonsalves and Mercer (7), 
manipulations causing any stress would 
result in an opposite behaviour of HR and 
SpO2. They compared vital parameters in 
preterm infants undergoing painful proce-
dures (injections, heel stick, tape removal) 
and non-painful procedures (handling, 
temperature taking, alcohol swabbing, 
feeding) and found an increase in HR and 
RR and a decrease in SpO2 in the painful 
procedure group. Our observation of re-
duction in HR and increase in SpO2 is in 
accordance with non-painful procedures.
The cTOI remained unchanged and pTOI 
increased slightly during the observation 
period. Catelin et al. (6) showed that cTOI 
itself may serve as a useful parameter to 
capture painful and stressful procedures in 
neonates that might show a decrease and 
an increase during behavioural interven-
tions. The lack of changes of cTOI in the 
present study further support the toler-
ability of NIRS measurements and venous 
occlusions.
In our study, using the KUSS score, we 
found no evidence of pain or discomfort 
brought upon infants by the NIRS meas-
urements. There are three categories of 
negative experiences for a newborn: pain, 
discomfort and general disturbances. (10) 
Important behavioural changes caused by 
pain in non-ventilated and non-sedated 
newborns are well captured by the KUSS 
score. NIRS is a non-invasive tool and 
therefore can be seen as non-painful. The 
KUSS score should have also captured any 
form of discomfort associated with NIRS 
measurements. However, additional dis-
turbances caused by manipulations asso-
ciated with NIRS measurements could be 
relevant. Integration of manipulation due 
to NIRS measurements into routine nurs-
ing handling schemes, might overcome an 
increased burden due to manipulation.
In regards to skin condition and integrity, 
with a mean measurement time of 61 min-
utes, we only evaluated short-term use. 
There were no skin irritations caused by 
cerebral measurements, but we observed 
signs of mild irritation in peripheral meas-
urements. No severe adverse reactions 
associated with long term cerebral NIRS 
measurements have been recorded, but 
skin marks have been reported in a larger 
randomized trial. (11) For the long-term 
use of NIRS, re-positioning of the sensor 
seems therefore to be appropriate to avoid 
problems.
In conclusion, cerebral and peripheral 
NIRS monitoring and venous occlusions 
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can be considered a painless, well toler-
ated, non-invasive method for monitoring 
cerebral and peripheral tissue oxygenation 
and haemodynamic status, which can in 
addition be well integrated into routine 
neonatal management.
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